Cystron Pharma Private Limited, a active private limited company, was established on 08 July 2011 in Secunderabad, Telangana, India. Engaging in api manufacturers within the hospital and medical care sector, it holds CIN: U24100TG2011PTC075439. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.10 Cr.
Formerly known as Panchakalyani Food Products Private Limited. It upholds a compliant status. Its leadership includes Prathivenkateswararao (Director), Sailendra Kotikalapudi (Additional Director), Venkata Subbu Sridhar Anantharaju (Director). Past directors included Prathivenkateswararao, Yellamelli Surekha, Praveen Kumar Jamjala. It holds ₹3.40 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 207, My Home Tycoon, Landmark - Lifestyle Building, Kundan Bagh, Secunderabad, Telangana, 500016.
U24100TG2011PTC075439
075439
08 July 2011
₹1.50 Cr
₹1.10 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Cystron Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prathivenkateswararao | Director | 09 Mar 2022 | Current |
| Sailendra Kotikalapudi | Additional Director | 25 Mar 2025 | Current |
| Venkata Subbu Sridhar Anantharaju | Director | 10 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Director | 16 Mar 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2024 | Past |
| Pramod Abcsdd | Director | 15 Mar 2022 | Past |
| Pramod Abcsdd | Director | 16 Mar 2016 | Past |
| Pramod Abcsdd | Additional Director | 13 May 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cystron Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 54.59% increase. The company also saw a substantial fall in profitability, with a 979.3% decrease in profit. The company's net worth Soared by an impressive increase of 345.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Cystron Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹34,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2021 | State Bank Of India | ₹3.40 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cystron Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cystron Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cystron Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sailendra Kotikalapudi was appointed as a Additional Director was appointed as a Additional Director on 25 Mar 2025 & has been associated with this company since 8 months 9 days . was recorded as a recent event.
Cystron Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Cystron Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on A charge with State Bank Of India of Rs. 3.40 Cr registered on 22 Mar 2021 with Charge ID 100440177 was modified on 28 Dec 2022. was documented.
Prathivenkateswararao was appointed as a Director was appointed as a Director on 09 Mar 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
The activity A charge with State Bank Of India amounted to Rs. 3.40 Cr with Charge ID 100440177 was registered on 22 Mar 2021. was completed.
The CIN of Cystron Pharma Private Limited is U24100TG2011PTC075439.
Cystron Pharma Private Limited is headquartered at 207, My Home Tycoon, Landmark - Lifestyle Building, Kundan Bagh, Secunderabad, Telangana, 500016.
Cystron Pharma Private Limited was incorporated on 08 July 2011.
The current directors of Cystron Pharma Private Limited are
The primary industry of Cystron Pharma Private Limited is Hospital And Medical Care.
Cystron Pharma Private Limited is unlisted.
The authorized capital of Cystron Pharma Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.10 Cr.
The compliance status of Cystron Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX